Galapagos NV ADR (GLPG)

NASDAQ
Currency in USD
Disclaimer
37.27
-0.28
(-0.75%)
Closed
37.27
0.00
(0.00%)
After Hours
Real-time Data
Day's Range
37.00
37.74
52 wk Range
36.20
72.11
Volume
181,770
Prev. Close
37.55
Open
37.41
Day's Range
37-37.74
52 wk Range
36.2-72.11
Volume
181,770
Average Vol. (3m)
273,387
1-Year Change
-40.05%
Shares Outstanding
65,897,071
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More

People Also Watch

Galapagos NV ADR News

Galapagos NV ADR Analysis

Galapagos NV ADR Company Profile

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor for the treatment of adults with rheumatoid arthritis (RA), and GLPG3667 that has completed Phase 1b trial. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.